000 | 02001ngm a2200469 a 4500 | ||
---|---|---|---|
001 | HST4071 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 150909s2015 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a4071 _bHenry Stewart Talks |
035 | _a(UkLoHST)3097 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aMcClung, Michael. _4spk |
|
245 | 1 | 0 |
_aPharmacotherapy of osteoporosis _h[electronic resource] : _bpart 2 of 2 / _cMichael McClung. |
246 | 3 | _aPharmacotherapy of osteoporosis. Part 2 | |
260 |
_aLondon : _bHenry Stewart Talks, _c2015. |
||
300 |
_a1 online resource (1 streaming video file (41 min.) : _bcolor, sound). |
||
490 | 1 |
_aBone in health and disease : bone physiology and osteoporosis, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Long-term Denosumab therapy -- Estrogen agonists/antagonists -- Parathyroid hormone analogues -- Strontium ranelate -- Combination therapy -- Warnings and precautions -- Choosing among treatments and drugs -- Preventing osteoporosis. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 |
_aOsteoporosis _xChemotherapy. |
|
650 | 0 |
_aOsteoporosis _xPrevention. |
|
650 | 0 |
_aOsteoporosis _xTreatment. |
|
650 | 2 | _aAntibodies, Monoclonal, Humanized. | |
650 | 2 |
_aBone and Bones _xphysiopathology. |
|
650 | 2 | _aDenosumab. | |
650 | 2 | _aOrganometallic Compounds. | |
650 | 2 |
_aOsteoporosis _xdrug therapy. |
|
650 | 2 |
_aOsteoporosis _xprevention & control. |
|
650 | 2 | _aParathyroid Hormone. | |
650 | 2 |
_aRANK Ligand _xantagonists & inhibitors. |
|
650 | 2 | _astrontium ranelate. | |
650 | 2 | _aThiophenes. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pBone in health and disease. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/3097/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/910/ _3Series |
999 |
_c76848 _d76848 |